Finally! Air Force Major Restored to a “Clean Slate”

USAF MAJ Aaron Elliott endured severe persecution and adverse actions, including official letters of reprimand in his otherwise exemplary record due to his application for exemption from the COVID shots.

Today’s Whistleblower Report explores the hard work and persistence it took to clear his record and emerge with finally a “clean slate” from all the damage that had been done: one Letter of Reprimand involved a 2,500 page-Rebuttal. He submitted two separate complaints to the Inspector General, three Whistleblower Reprisal Complaints, three Military Equal Opportunity Complaints, and three Congressional Inquiries conducted on his behalf against his chain of command. He also submitted a Religious Accommodation Request Appeal to the Secretary of the Air Force and another memo detailing discrepancies between the Air Force’s religious regulation and the Department of Defense’s Instruction on Religion.

Legal Report: Major Airlines Continued Attack on Pilots & Aviation Safety

Captain Bahig Saliba is literally the only currently employed airline pilot in the country whose services as a pilot are still being blocked over the unlawful COVID mandates, even in the face of a pilot shortage at all the major airlines.

Captain Saliba emigrated to the US and began his flying career in 1984 as a flight instructor for fixed-wing and rotorcraft helicopters. He worked for several airlines before finally joining the current airline in 1997, where he has been a Captain at the airline since 2004. He is laser-focused on safety and has an impeccable record as a pilot.

Bill Gates human vulture and nemesis to humanity

Inside Pharma Report: Bill Gates Mastermind Behind Capturing Global Health Regulatory Agencies?

Evidence is mounting that this is the case as our Whistleblowers –Hedley Rees from the UK and international attorney Dr. Reiner Fuellmich—discuss today with US physician Dr. Vliet. Inside Pharma host Hedley Rees also exposes the surreptitious steps the Medicines and Health Products Regulatory Agency (MHRA) has taken to change its Regulations to allow gene therapies, and other advanced medicinal products, to be manufactured without the safety umbrella of there being a proper Quality Management System in place. Read more here: Subject: FOI Request—substantial change in 2022 edition of Rules and Guidance for Pharmaceutical Manufacturers and Distributors: PART IV “Guidelines on Good Manufacturing Practice Specific to Advanced Therapy Medicinal Products (ATMPs)